Total Payments
$30,104
2024 Payments
$1,628
Companies
36
Transactions
176
Medicare Patients
3,496
Medicare Billing
$429,926
Payment Breakdown by Category
Other$16,295 (54.1%)
Food & Beverage$7,340 (24.4%)
Travel$3,894 (12.9%)
Consulting$2,462 (8.2%)
Education$113.37 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,295 | 9 | 54.1% |
| Food and Beverage | $7,340 | 151 | 24.4% |
| Travel and Lodging | $3,894 | 10 | 12.9% |
| Consulting Fee | $2,462 | 2 | 8.2% |
| Education | $113.37 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $22,285 | 35 | $0 (2019) |
| United Therapeutics Corporation | $1,494 | 20 | $0 (2024) |
| TRANSMEDICS, INC. | $705.80 | 1 | $0 (2021) |
| Genentech USA, Inc. | $681.35 | 12 | $0 (2023) |
| Astellas Pharma US Inc | $672.60 | 18 | $0 (2024) |
| La Jolla Pharmaceutical Company | $559.24 | 5 | $0 (2023) |
| Genentech, Inc. | $419.53 | 3 | $0 (2021) |
| Paragonix Technologies, Inc. | $395.76 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $392.93 | 7 | $0 (2024) |
| The Medicines Company | $223.42 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,628 | 42 | Paragonix Technologies, Inc. ($330.86) |
| 2023 | $1,091 | 33 | Vapotherm Inc ($147.02) |
| 2022 | $1,187 | 21 | La Jolla Pharmaceutical Company ($505.48) |
| 2021 | $1,695 | 14 | TRANSMEDICS, INC. ($705.80) |
| 2020 | $308.37 | 7 | United Therapeutics Corporation ($235.93) |
| 2019 | $14,996 | 27 | Gilead Sciences, Inc. ($14,144) |
| 2018 | $5,650 | 17 | Gilead Sciences, Inc. ($5,049) |
| 2017 | $3,549 | 15 | Gilead Sciences Inc ($3,092) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 10/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 09/10/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/09/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 08/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/19/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $112.50 | General |
| 07/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/03/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Infectious Diseases | ||||||
| 06/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $61.99 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Cardiology | ||||||
| 06/25/2024 | United Therapeutics Corporation | Steen Solution (Device), TYVASO | Food and Beverage | In-kind items and services | $52.57 | General |
| Category: Lung Transplant | ||||||
| 06/24/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/13/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology | ||||||
| 05/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | Paragonix Technologies, Inc. | SherpaPak (Device), LiverGuard, LungGuard | Food and Beverage | In-kind items and services | $208.55 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 710 | 1,251 | $326,296 | $85,374 |
| 2022 | 19 | 1,282 | 2,387 | $584,710 | $147,691 |
| 2021 | 20 | 972 | 1,698 | $407,494 | $108,141 |
| 2020 | 12 | 532 | 1,015 | $342,171 | $88,720 |
Total Patients
3,496
Total Services
6,351
Medicare Billing
$429,926
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 135 | 272 | $120,496 | $30,119 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 313 | $99,063 | $28,930 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 78 | $17,870 | $4,760 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 49 | $15,621 | $4,088 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 49 | 51 | $15,106 | $3,789 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 27 | $16,146 | $3,414 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $10,350 | $2,691 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 46 | $9,420 | $2,269 | 24.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,665 | $1,309 | 23.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 33 | 45 | $5,040 | $1,190 | 23.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 102 | 130 | $3,250 | $838.40 | 25.8% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 45 | 45 | $3,081 | $759.81 | 24.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 80 | 81 | $2,331 | $554.61 | 23.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 50 | 50 | $1,974 | $465.99 | 23.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 25 | 25 | $883.00 | $195.84 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 185 | 469 | $208,817 | $54,445 | 26.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 549 | $172,602 | $46,566 | 27.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 46 | $28,054 | $7,454 | 26.6% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 31 | 51 | $27,762 | $7,176 | 25.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 45 | 62 | $19,926 | $5,194 | 26.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 39 | 93 | $37,343 | $4,145 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 43 | 44 | $13,453 | $3,474 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $11,628 | $3,114 | 26.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $11,271 | $3,016 | 26.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 265 | 437 | $11,556 | $2,903 | 25.1% |
About Dr. Kapilkumar Patel, M.D
Dr. Kapilkumar Patel, M.D is a Pulmonary Disease healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356416531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kapilkumar Patel, M.D has received a total of $30,104 in payments from pharmaceutical and medical device companies, with $1,628 received in 2024. These payments were reported across 176 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,295).
As a Medicare-enrolled provider, Patel has provided services to 3,496 Medicare beneficiaries, totaling 6,351 services with total Medicare billing of $429,926. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Winston Salem, NC
- Active Since 11/22/2006
- Last Updated 01/13/2026
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1356416531
Products in Payments
- Cayston (Drug) $21,308
- ORGAN CARE SYSTEM (Device) $705.80
- Cresemba (Drug) $596.47
- ORENITRAM (Drug) $568.72
- GIAPREZA (Drug) $559.24
- Actemra (Biological) $419.53
- SherpaPak (Device) $330.86
- ACTHAR (Biological) $292.22
- XARELTO (Drug) $204.44
- PURIFIED CORTROPHIN GEL (Drug) $187.32
- OFEV (Drug) $184.67
- ORBACTIV (Drug) $159.41
- TYVASO (Drug) $156.06
- NONE (Drug) $155.00
- OPSUMIT (Drug) $152.31
- VAPOTHERM (Device) $147.02
- BREZTRI (Drug) $127.04
- METRA (Device) $126.80
- Adempas (Drug) $125.00
- REMODULIN (Drug) $124.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Winston Salem
Jill Ohar, Md, MD
Pulmonary Disease — Payments: $365,275
Pulmonary Disease $365,275
Victor Ortega, M.d, M.D
Pulmonary Disease — Payments: $48,918
Pulmonary Disease $48,918
Dr. Christina Bellinger, Md, MD
Pulmonary Disease — Payments: $19,514
Pulmonary Disease $19,514
Dr. Benjamin Bregman, M.d, M.D
Pulmonary Disease — Payments: $13,437
Pulmonary Disease $13,437
Dr. Farhan Ahmed, M.d, M.D
Pulmonary Disease — Payments: $8,257
Pulmonary Disease $8,257
Dr. Andrew Namen, M.d, M.D
Pulmonary Disease — Payments: $8,214
Pulmonary Disease $8,214